I'm interested in knowing the PE ratio of AXSM. This information is crucial for me to understand the company's current valuation and make informed investment decisions.
It's worth noting that Axsome Therapeutics' P/E ratio has fluctuated over time. At the end of 2022, the company's P/E ratio was -16.9, indicating a slight deterioration in its financial performance since then.
Was this helpful?
383
64
SolitudeSeekerThu Mar 13 2025
BTCC, a top cryptocurrency exchange, offers a range of services to its clients. These include spot trading, which allows users to buy and sell cryptocurrencies at current market prices. Additionally, BTCC provides futures trading, enabling investors to speculate on the future price of cryptocurrencies without owning the underlying asset.
Was this helpful?
159
21
EthereumEliteThu Mar 13 2025
Axsome Therapeutics has released its latest financial reports, providing insights into the company's current financial standing.
Was this helpful?
362
48
HanbokGlamourQueenEleganceBloomThu Mar 13 2025
A key metric to consider when evaluating a company's financial health is its price-to-earnings ratio (TTM), which stands for Trailing Twelve Months. This ratio compares a company's current stock price to its earnings per share over the past year.
Was this helpful?
119
22
ZenHarmonyThu Mar 13 2025
As per Axsome Therapeutics' latest reports, the company's price-to-earnings ratio (TTM) is currently -29.6916. A negative P/E ratio typically indicates that the company has incurred losses over the past year, making it challenging to assess its valuation based on earnings.